| Product NDC: | 43063-023 | 
| Proprietary Name: | Propoxyphene and Acetaminophen | 
| Non Proprietary Name: | propoxyphene napsylate and acetaminophen | 
| Active Ingredient(s): | 650; 100 1/1; mg/1 & nbsp; propoxyphene napsylate and acetaminophen | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 43063-023 | 
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA074843 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20100510 | 
| Package NDC: | 43063-023-04 | 
| Package Description: | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-023-04) | 
| NDC Code | 43063-023-04 | 
| Proprietary Name | Propoxyphene and Acetaminophen | 
| Package Description | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-023-04) | 
| Product NDC | 43063-023 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | propoxyphene napsylate and acetaminophen | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20100510 | 
| Marketing Category Name | ANDA | 
| Labeler Name | PD-Rx Pharmaceuticals, Inc. | 
| Substance Name | ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE | 
| Strength Number | 650; 100 | 
| Strength Unit | 1/1; mg/1 | 
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |